Thursday, October 16, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Optimistic Analyst Outlook and Price Targets for Kemper KMPR

Elaine Mendonca by Elaine Mendonca
January 26, 2024
in Breaking News
0
Insurance company Markets and money
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

As of January 26, 2024, the evaluations and price targets for Kemper (NYSE: KMPR) have shown a generally optimistic outlook. Here are the key takeaways:

Analyst Ratings
Over the past three months, four analysts have provided their evaluations of Kemper. Among them, two analysts have expressed a bullish outlook, while the other two have shown a somewhat bullish sentiment.

Price Targets
The average 12-month price target for Kemper stands at $63.0, with a high estimate of $70.00 and a low estimate of $56.00. This represents a 13.51% increase compared to the previous average price target of $55.50.

Recent Analyst Actions
C. Gregory Peters from Raymond James has upgraded the rating to Strong Buy, setting a current price target of $70.00, up from $60.00. Similarly, Paul Newsome from Piper Sandler has raised the rating to Overweight, with a current price target of $66.00, up from $56.00. Newsome has also increased another Overweight rating to $56.00 from $47.00. Additionally, Brian Meredith from UBS has upgraded the rating to Buy, setting a current price target of $60.00, up from $59.00.

Additional Insights
Based on five buy ratings and no hold or sell ratings, Kemper has received a consensus rating of Strong Buy. According to TipRanks, the average price target for the company is $64.20, with a high forecast of $70.00. The company’s average rating score is 3.17, based on the five buy ratings.

Overall, analysts have shown a positive sentiment towards Kemper, as evidenced by the increase in price targets and bullish ratings. This indicates confidence in the company’s future performance.

Kansas City Life Insurance Company (KMPR) Demonstrates Strong Stock Performance with Resilience and Investor Confidence

On January 26, 2024, Kansas City Life Insurance Company (KMPR) exhibited strong stock performance, trading near the top of its 52-week range and above its 200-day simple moving average. The stock showed positive price momentum, with a significant increase of $4.09 since the market last closed, representing a rise of 7.07%.

Closing at $61.90, KMPR showcased its resilience and investor confidence. However, in after-hours trading, the stock experienced a slight drop of $0.20. While this drop may be seen as a minor setback, it is important to consider the overall positive performance of the stock throughout the day.

Kemper Corporation (KMPR) Stock Performance Declines: Revenue, Net Income, and EPS Show Downward Trend

Kemper Corporation (KMPR) experienced a decline in its stock performance on January 26, 2024. The company’s total revenue, net income, and earnings per share showed a downward trend compared to the previous year and the previous quarter.

Starting with total revenue, Kemper Corporation generated $5.60 billion in the last year, but this figure decreased by 3.48% compared to the previous year. In the third quarter, the company’s total revenue was $1.20 billion, which represented a 5.0% decrease compared to the previous quarter.

The decline in total revenue was reflected in the company’s net income as well. Kemper Corporation reported a net income of -$301.20 million in the last year, indicating a significant decrease of 149.96% compared to the previous year. In the third quarter, the company’s net income was -$146.30 million, which represented a 50.67% decrease compared to the previous quarter.

The negative trend continued with the company’s earnings per share (EPS). Kemper Corporation reported an EPS of -$4.72 in the last year, reflecting a decrease of 151.67% compared to the previous year. In the third quarter, the company’s EPS was -$2.28, representing a 50.55% decrease compared to the previous quarter.

These financial indicators suggest that Kemper Corporation faced challenges in generating revenue and profitability during the specified periods. The decrease in total revenue and net income indicates a decline in the company’s overall financial performance. Additionally, the negative EPS figures highlight the company’s struggle to generate earnings for its shareholders.

Investors and stakeholders may be concerned about Kemper Corporation’s financial performance, as the downward trend in revenue, net income, and EPS raises questions about the company’s ability to sustain profitability. It is important to note that these figures represent a specific point in time and may not reflect the company’s overall financial health or its future prospects.

As with any investment, it is crucial for investors to conduct thorough research and analysis before making any decisions. Assessing a company’s financial performance, industry trends, and other relevant factors can provide a more comprehensive understanding of its stock performance.

Tags: KMPR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Stock Charts (2)

Analyzing Insider Sales Understanding the Bigger Picture

Finance_ Investing in stocks

The Impact of Currency Devaluation on American Expresss Financial Performance

Healthcare Services Stock Exchange

Femasys Inc Initiates Enrollment for Pivotal Trial of Groundbreaking Permanent Birth Control Candidate FemBloc

Recommended

Kazatomprom JSC NAC Stock

Uranium Rally Powers Kazatomprom Shares to New Heights

3 days ago

Revised Price Target Indicates Positive Outlook for Linde NYSE LIN

2 years ago
Empowering Remote Regions: the Nano Grid Technology for Reliable Electricity Solutions

FTC Solar Reports Mixed Q4 Financial Results with Focus on Future Growth

2 years ago
Finance_ projections

Understanding Trading Halts and Resumptions Guidelines and Considerations

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Generation Bio at a Critical Juncture: Survival Strategy Meets Scientific Promise

Hope Bancorp’s Critical Test: Can Q3 Earnings Restore Investor Confidence?

All Eyes on Ribbon Communications as Quarterly Report Looms

LSI Industries Stock: Technical Indicators Paint Conflicting Picture

Bloomin’ Brands Stock Plummets Despite Earnings Beat

Goldman Sachs Boosts Stake in Defense Giant Rheinmetall Amid Major Contract Wins

Trending

Red Cat Holdings Stock
Analysis

Drone Maker Red Cat Faces Investor Confidence Crisis

by Robert Sasse
October 16, 2025
0

The shares of drone manufacturer Red Cat have become the center of a dramatic tug-of-war between promising...

iShares MSCI World ETF Stock

Is the iShares MSCI World ETF Set to Benefit from Monetary Easing?

October 16, 2025
Apple Stock

Apple’s Strategic Shift: M5 Chip Deployment Aims to Reignite Growth

October 16, 2025
Generation Bio Co Stock

Generation Bio at a Critical Juncture: Survival Strategy Meets Scientific Promise

October 16, 2025
Hope Stock

Hope Bancorp’s Critical Test: Can Q3 Earnings Restore Investor Confidence?

October 16, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Drone Maker Red Cat Faces Investor Confidence Crisis
  • Is the iShares MSCI World ETF Set to Benefit from Monetary Easing?
  • Apple’s Strategic Shift: M5 Chip Deployment Aims to Reignite Growth

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com